Unclassified Renal Cell Carcinoma With Significant Response to Nivolumab

Research output: Contribution to journalArticle

4 Citations (Scopus)
Original languageEnglish (US)
JournalClinical Genitourinary Cancer
DOIs
StateAccepted/In press - Dec 17 2016

Fingerprint

Kidney Neoplasms
Renal Cell Carcinoma
Immunotherapy
Therapeutics
nivolumab

Keywords

  • Immunotherapy
  • Kidney cancer
  • Therapeutic
  • Unclassified renal cancer
  • Undifferentiated

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this

@article{5bc6e9fe8ef0432ea4a1c8c0f9a443e4,
title = "Unclassified Renal Cell Carcinoma With Significant Response to Nivolumab",
keywords = "Immunotherapy, Kidney cancer, Therapeutic, Unclassified renal cancer, Undifferentiated",
author = "Nabil Adra and Liang Cheng and Roberto Pili",
year = "2016",
month = "12",
day = "17",
doi = "10.1016/j.clgc.2016.12.019",
language = "English (US)",
journal = "Clinical Genitourinary Cancer",
issn = "1558-7673",
publisher = "Elsevier",

}

TY - JOUR

T1 - Unclassified Renal Cell Carcinoma With Significant Response to Nivolumab

AU - Adra, Nabil

AU - Cheng, Liang

AU - Pili, Roberto

PY - 2016/12/17

Y1 - 2016/12/17

KW - Immunotherapy

KW - Kidney cancer

KW - Therapeutic

KW - Unclassified renal cancer

KW - Undifferentiated

UR - http://www.scopus.com/inward/record.url?scp=85009480300&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009480300&partnerID=8YFLogxK

U2 - 10.1016/j.clgc.2016.12.019

DO - 10.1016/j.clgc.2016.12.019

M3 - Article

C2 - 28110836

AN - SCOPUS:85009480300

JO - Clinical Genitourinary Cancer

JF - Clinical Genitourinary Cancer

SN - 1558-7673

ER -